InnovationFDA Issues Alert on Smartwatches, Smart Rings for Diabetes Management
The agency is warning that no devices have been approved that can accurately measure a user?s blood glucose without piercing...
PayerStates target health insurers’ ‘prior authorization’ red tape
A spokesperson for Cigna says the insurer uses prior authorizations for popular drugs such as Mounjaro to help ensure that...
InnovationKaiser Permanente Launches Medicaid-Based ‘Food is Medicine’ Study
As the HLTH conference kicks into gear in Las Vegas, Kaiser Permanente has launched a collaboration with Instacart to study...
PharmaNovo Nordisk, Valo Health $2.7B Deal Taps AI to Develop New Treatments for Cardiometabolic Diseases
The collaboration could expand to 'the entire drug discovery continuum', the two companies say.
Clinical CareContributed Content: Addressing Patient Needs Through Centralized Wellness Referral Center
Presbyterian Healthcare Services' centralized wellness referral center connects patients in two historically under-resourced communities to health resources.
PharmaLawyer's Rezolute on track for late-stage studies for hypoglycemia and diabetic macular edema treatments
As an advisor to hundreds of therapeutic and tech startups over the years, this innovator observed both good and bad...
Clinical CareLiver Disease Specialist: Obesity Has Reached Crisis Proportions
A recent report found that 42% of U.S. adults are obese.
Clinical CareNearly Half of U.S. Adults Are Obese
A new NORC interactive map provides state-level data on obesity rates and related chronic diseases.
PharmaCivica Rx to Supply California's $30 Insulin
CalRx will offer biosimilars for Glargine, Aspart, and Lispro, which are expected to be interchangeable with Lantus, Humalog, and Novolog...
PharmaLilly Slashes Insulin Prices by 70%. Will Novo Nordisk, Sanofi Follow?
Lilly's announcement puts pressure to follow suit on competitors Novo Nordisk and Sanofi.
PharmaCA AG Sues Insulin Makers, PBMs for Price Gouging
Eli Lilly, Novo Nordisk, Sanofi, CVS Caremark, Express Scripts, and OptumRx are accused of overcharging patients.
TechnologyWhy Technology is Integral to Diabetes Care Management
In its 2023 Standards of Care, the American Diabetes Association says technology is now a vital part of care management,...